PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II...
Leadership
Frank K. Bedu-Addo Ph.D.
President, CEO & Director
Stephan Toutain M.B.A., M.S.
Chief Operating Officer
Kirk V. Shepard M.D.
Chief Medical Officer
Lars Robert Boesgaard M.B.A.
Principal Financial & Accounting Officer and CFO
Gregory L. Conn Ph.D.
Chief Scientific Officer
Spencer Brown J.D.
Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer
